We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$170B
Turnover
10.63%
1-Year Est. Return
46.21%
This Fund
S&P 500
This Quarter
Est. Return
+12.23%
1 Year Est. Return
+46.21%
3 Year Est. Return
+117.8%
5 Year Est. Return
+135.17%
10 Year Est. Return
+586.77%
AUM
$124B
AUM Growth
+$11.4B
(+10%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
0.76%
Top 10 Holdings %
Top 10 Hldgs %
10.89%
Holding
2,727
New
194
Increased
1,215
Reduced
1,167
Closed
142
Avg Time Held
5.5
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
|
+$704M |
| 2 |
ExxonMobil
XOM
|
+$488M |
| 3 |
PepsiCo
PEP
|
+$288M |
| 4 |
Dover
DOV
|
+$262M |
| 5 |
Abbott
ABT
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NASDAQ-100 Technology Index Fund
QTEC
|
+$698M |
| 2 |
Philip Morris
PM
|
+$400M |
| 3 |
AbbVie
ABBV
|
+$215M |
| 4 |
IBM
IBM
|
+$214M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.62% |
| 2 | Financials | 15.15% |
| 3 | Industrials | 14.51% |
| 4 | Consumer Discretionary | 8.26% |
| 5 | Healthcare | 6.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
651
Takeda Pharmaceutical
TAK
$62.1B
| $40.2M | 0.03% |
2,601,808
-154,147
| -6% | -$2.28M |
2024 Q3
3 quarters
|
|
652
Emera Inc
EMA
$14.5B
| $40.2M | 0.03% |
+877,444
| New | +$39.4M |
2025 Q2
0 quarters
|
|
653
The Greenbrier Companies
GBX
$1.22B
| $40.2M | 0.03% |
872,748
+346,039
| +66% | +$15.5M |
2023 Q1
9 quarters
|
|
654
Dynatrace
DT
$18.4B
| $40.1M | 0.03% |
726,094
+338,845
| +88% | +$17M |
2019 Q4
22 quarters
|
|
655
Alkermes
ALKS
$6.73B
| $40M | 0.03% |
1,397,281
-223,765
| -14% | -$6.66M |
2013 Q3
47 quarters
|
|
656
Halozyme
HALO
$13.8B
| $39.8M | 0.03% |
765,918
-37,776
| -5% | -$2.15M |
2020 Q1
21 quarters
|
|
657
Mettler-Toledo International
MTD
$32.8B
| $39.8M | 0.03% |
33,900
+448
| +1% | +$501K |
2018 Q4
26 quarters
|
|
658
Royalty Pharma
RPRX
$26.5B
| $39.8M | 0.03% |
1,104,044
-495,192
| -31% | -$16.4M |
2023 Q3
7 quarters
|
|
659
Enphase Energy
ENPH
$4.07B
| $39.7M | 0.03% |
1,000,413
+31,403
| +3% | +$1.45M |
2018 Q1
29 quarters
|
|
660
Corcept Therapeutics
CORT
$12.3B
| $39.4M | 0.03% |
537,186
-387,131
| -42% | -$28.1M |
2019 Q1
25 quarters
|
|
661
FedEx
FDX
$69.9B
| $39.2M | 0.03% |
172,550
+37,298
| +28% | +$8.17M |
2013 Q2
48 quarters
|
|
662
Bruker
BRKR
$8.61B
| $39.2M | 0.03% |
951,802
+257,755
| +37% | +$9.95M |
2017 Q2
32 quarters
|
|
663
Enbridge
ENB
$104B
| $39.1M | 0.03% |
863,703
-82,075
| -9% | -$3.72M |
2024 Q1
5 quarters
|
|
664
Advanced Energy
AEIS
$10.1B
| $39.1M | 0.03% |
294,775
+24,422
| +9% | +$2.69M |
2013 Q2
48 quarters
|
|
665
Sensient Technologies
SXT
$5.68B
| $39M | 0.03% |
396,086
-179,601
| -31% | -$16.1M |
2016 Q2
36 quarters
|
|
666
DELISTED
Comerica
CMA
| $39M | 0.03% |
654,103
+69,392
| +12% | +$3.87M |
2013 Q2
48 quarters
|
|
667
Baxter International
BAX
$13.3B
| $39M | 0.03% |
1,287,832
-250,792
| -16% | -$7.6M |
2016 Q2
36 quarters
|
|
668
Canadian National Railway
CNI
$72.9B
| $39M | 0.03% |
374,763
-44,504
| -11% | -$4.53M |
2020 Q4
18 quarters
|
|
669
Permian Resources
PR
$19.8B
| $38.9M | 0.03% |
2,854,877
+348,458
| +14% | +$4.48M |
2021 Q1
17 quarters
|
|
670
DELISTED
Kellanova
K
| $38.8M | 0.03% |
487,843
-284,946
| -37% | -$23.3M |
2013 Q2
48 quarters
|
|
671
DELISTED
Exact Sciences
EXAS
| $38.8M | 0.03% |
729,930
-18,983
| -3% | -$964K |
2016 Q4
34 quarters
|
|
672
Honda
HMC
$44.2B
| $38.7M | 0.03% |
1,343,158
-45,534
| -3% | -$1.33M |
2024 Q2
4 quarters
|
|
673
Best Buy
BBY
$19.8B
| $38.7M | 0.03% |
576,824
-93,598
| -14% | -$6.36M |
2013 Q2
48 quarters
|
|
674
Chord Energy
CHRD
$8.11B
| $38.7M | 0.03% |
399,628
+11,785
| +3% | +$1.12M |
2021 Q2
16 quarters
|
|
675
GSK
GSK
$98.2B
| $38.6M | 0.03% |
1,004,799
-71,321
| -7% | -$2.73M |
2024 Q1
5 quarters
|
|
Similar funds
First Trust Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, First Trust Advisors held 2,727 positions worth $124B, up 10% from $113B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
First Trust Advisors's Q2 2025 filing shows 194 new, 1,215 increased, 1,167 reduced and 142 closed positions. Its largest new stake was First Trust NASDAQ 100 ex-Technology Sector Index Fund: 7,413,411 shares worth $732M. The largest sale was First Trust NASDAQ-100 Technology Index Fund, an estimated $698M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Financials and Industrials.
- First Trust Advisors's largest Q2 2025 buy was First Trust NASDAQ 100 ex-Technology Sector Index Fund: 7,413,411 shares worth $732M.
- First Trust Advisors added most to ExxonMobil in Q2 2025, an estimated $488M increase.
- First Trust Advisors's biggest Q2 2025 reduction was Philip Morris, cutting an estimated $400M.
- First Trust Advisors fully exited First Trust NASDAQ-100 Technology Index Fund in Q2 2025, selling an estimated $698M.
- First Trust Advisors's ten largest holdings make up 11% of its $124B portfolio in Q2 2025.
- First Trust Advisors opened 194 new positions and closed 142 in Q2 2025.
- First Trust Advisors's portfolio value rose 10% quarter-over-quarter to $124B.
Based on First Trust Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.